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Abstract
Background: Triterpene alcohols and acids are multifunctional compounds widely distributed throughout the plant
kingdom that exhibit a variety of beneficial health properties, being synthetic analogs of oleanolic acid under clinical
evaluation as anti-tumoral therapeutic agents. However, the antineoplastic activity of two natural occuring triterpenoid
alcohols extracted from olive oil, erythrodiol (an intermediate from oleanolic acid), and its isomer, uvaol, has barely been
reported, particularly on brain cancer cells. Astrocytomas are among the most common and aggressive type of primary
malignant tumors in the neurological system lacking effective treatments, and in this study, we addressed the effect of
these two triterpenic diols on the human 1321N1 astrocytoma cell line.
Principal Findings: Erythrodiol and uvaol effectively affected cell proliferation, as well as cell cycle phases and induced
1321N1 cell death. Both triterpenes successfully modulated the apoptotic response, promoting nuclear condensation and
fragmentation. They caused retraction and rounding of cultured cells, which lost adherence from their supports, while F-
actin and vimentin filaments disappeared as an organized cytoplasmic network. At molecular level, changes in the
expression of surface proteins associated with adhesion or death processes were also observed. Moreover, triterpene
exposure resulted in the production of reactive oxygen species (ROS) with loss of mitochondrial transmembrane potential,
and correlated with the activation of c-Jun N-terminal kinases (JNK). The presence of catalase reversed the triterpenic diols-
induced mitochondrial depolarization, JNK activation, and apoptotic death, indicating the critical role of ROS in the action of
these compounds.
Conclusions: Overall, we provide a significant insight into the anticarcinogenic action of erythrodiol and uvaol that may
have a potential in prevention and treatment of brain tumors and other cancers.
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Introduction
Improvements in current cancer treatment regimens have
resulted in an increase in patient survival. Nevertheless, many
tumors, particularly astrogliomas, the most common primary
brain tumors, relapse and are resistant to subsequent treatments.
Several obstacles prevent the complete eradication of these high-
grade malignant neoplasms by conventional therapies: i) their
ability to infiltrate the surrounding normal brain, rendering total
surgical excision highly improbable [1], ii) their low response or
resistance to chemotherapy, and specially iii) their physical
isolation from systemic circulation due to the impermeability of
the blood–brain barrier (BBB), which limits transport of most
hidrophilic and large lipophilic molecules, thus preventing more
than 95% of drugs from penetrating the brain [2]. Therefore,
search new drugs or how to get these drugs across the natural
guardian of the brain, the BBB, is the cutting edge research to find
solutions to these highly invasive tumors.
Accumulating data indicate that the cytotoxic effect of many
chemotherapeutic drugs occurs through programmed cell death
(apoptosis) [3]. Hence, the ability of tumor cells to respond and
activate the apoptotic program may, in part, determine the success
of the therapeutic strategy [4]. It is well documented that apoptosis
can be induced by a variety of drugs with diverse chemical
structure and different mechanism of action; and two major routes
including the death-receptor pathway and the mitochondrial-
pathway have been identified [5]. Apoptosis is a highly regulated
process that involves many proteins and genes [6,7]. It is
characterized by cell shrinkage, plasma membrane bebbling, and
chromatin condensation. The death program is executed by
caspases, which amplify the apoptotic signal and proteolytically
process numerous cellular molecules with different functions [8].
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In response to death stimuli, ROS accumulation and alterations in
the mitochondrial membrane potential (DYm) are considered to be
early events [9]. In addition, mitogen-activated protein kinases
(MAPK) have also been considered as an upstream signal for the
initiation of apoptosis. Many studies have shown that the stress-
activated protein kinases pathway are rapidly activated in response
to oxidative insults and are frequently associated with cell death.
Thus, their activation is usually correlated with apoptosis induced
by agents that act, at least in part, via ROS generation [10–13].
A critical genetic defect in many tumors, including gliomas, is
found in the p53 gene, which makes p53 non-functional.
Normally, p53 sensitizes the tumor cell to chemotherapy, which
will induce programmed cell death. Thus, the search for effective
agents to treat a broad spectrum of tumors that differ in the
expression levels or in the mutational status of p53, are objectives
of drug development programs. At present, it has been reported
that members of the natural occurring triterpene family such as
boswellic, maslinic, ursolic or betulinic acid among others, are
potent apoptotic agents to cancer cells regardless of their p53
status (null, wild-type or mutant) [14,15].
Triterpenes are compounds widely available in fruits and
vegetables in human diet, as in the components of natural herbal
preparations used for the treatment of human diseases. Chemically
pentacyclic triterpenes are all based on a 30-carbon skeleton
comprising five six-membered rings (ursanes and oleananes) or
four six-membered rings and one five-membered ring (lupanes),
and as lipophilic molecules may also penetrate the blood-brain
barrier, as it has already been demonstrated for some of them.
[16–18]. The plant Olea europaea, the origin of the cultivated olive,
is widespread in Mediterranean countries, and extracts of its
leaves, flowers and fruits possess therapeutic properties and have
been used traditionally for medicinal purposes [19–22]. Among
the major components present in the unsaponifiable fraction of
olive-pomace oil are the triterpenic acids, oleanolic and maslinic
acids and the triterpenic diols, uvaol and erythrodiol [23]. Many
pharmacological properties of these compounds have been
reported. Thus, antiparasitic [24], hepatoprotective [25], anti-
VIH [26], anti-inflammatory and antioxidant activities [27,28]
have been attributed to them. In addition, recent ‘‘in vivo’’ studies
have demonstrated the benefits of oleanolic acid in preventing
hypertension [29]. Indeed, oleanolic acid, as well as uvaol and the
maslinic acid derivative, methyl maslinate, have also been shown
to possess vasodepressor, cardiotonic, and antidysrhythmic
properties [30]. Furthermore, they are able to induce vasorelax-
ation in the aorta of hypertensive rats [31]. And recently, it has
been suggested that erythrodiol derivatives can prevent the
harmful effects of ultraviolet rays that lead to skin aging or skin
cancer [32].
In the course of the search for potential antitumor promoters
from natural sources, the anticancer effect of these triterpenes
started to draw attention. Several studies have suggested that both
acidic and alcoholic triterpenes present anti-tumor activities
[33,34]. Although they markedly differ in their cytotoxic activity
and the precise mechanism of action is still unclear, especially for
the triterpenic diols. Thus, oleanolic and maslinic acids are
powerful pro-apoptotic agents in human colon cancer cells
[35,36], while uvaol show weak activity against an array of
human cancer cell lines from different tissues [34]. However,
although in a recent study we found that oleanolic and maslinic
acids are potent inducers of apoptosis in astroglioma cells, to date,
there is still little data available regarding their effects, as well as of
the rest of the natural triterpenoids, in brain cancer cells [37].
Therefore, we propose to examine on astroglial tumor cells, the
anti-proliferative and pro-apoptotic activities of the erythrodiol, an
intermediate of oleanolic and maslinic acid, and its isomer, the
ursane diol uvaol, as well as to elucidate the role of ROS in the
anti-neoplasic activities of these promising bioactive compounds.
Results
Effect of erythrodiol and uvaol on 1321N1 cell
attachment
First of all, commercial erythrodiol and uvaol (Figure 1) were
assessed for purity and identity by GC/MS (Figure S1), a method
that is based on the derivatisation of these molecules by silylation
with TMSIM as recommended procedure. Figure S1A and C
show the chromatographic peaks of the uvaol and erythrodiol
samples with retention times at 30.7 and 29.7 minutes,
respectively. The peak purity was of 99%, which can be
considered a pure compound. Chromatograms B and D, show
the corresponding mass spectra of the silylated molecules, which
were in close agreement with those fragmentation patterns
reported in the literature for these compounds (Wiley Registry of
Mass Spectral data base).
Figure 1. Molecular structure of uvaol and erythrodiol.
doi:10.1371/journal.pone.0005975.g001
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After that, we moved on to characterize their biological
activities. In a primary screening test, we found that the alcoholic
triterpenes, erythrodiol and uvaol, were able to modify astrocy-
toma cell morphology in a dose- and time-dependent manner
(Fig. 2). Under the phase-contrast microscope, 1321N1 astrocytes
cultured in normal conditions showed an adherent monolayer and
a large flat and polygonal shape; however, following 6 h of
exposure to different doses of erythrodiol or uvaol, cell
morphology changed dramatically. There was a morphological
response characterized by cytoplasmic retraction and rounding-up
of the cell body, compared to untreated cells (Fig. 2A upper panels).
Although both triterpenes displayed similar changes, cells were
more sensitive to erythrodiol. Thus, the morphological transfor-
mation induced by erythrodiol was detectable at 25 mM and
maximum at 50 mM, while uvaol response at 25 mM was barely
visible. Therefore, the concentrations chosen for the time-course
experiments were 25 mM for erythrodiol and 50 mM for uvaol. As
shown in Figure 2A (lower panels), the rate of morphological
transformation was similar for both triterpenes. After 8 h of
treatment cells began to detach from the culture flask, and by 18 h
were seen in aggregates as clusters of rounded cells.
Next, we studied the modulation of surface molecules such as
ICAM-1, VCAM-1 or CD44, since alterations in their expression
levels could cause changes in cell-substrate adhesion and/or in
homotypic cell-cell contact (Fig. 2B). By flow cytometry analysis,
resting 1321N1 cells showed immunofluorescence above unespe-
cific levels with antibodies to ICAM-1 and CD44, but not with
antibody to VCAM-1. Incubation for 18 h with different doses of
erythrodiol or uvaol, significantly diminished the expression levels
of CD44, while VCAM-1 and ICAM-1 immunoreactivity was
markedly increased.
Erythrodiol and uvaol induce morphological changes in
1321N1 cells
Cytoskeletal elements are known to be involved in determining
cell shape and cellular contacts. In order to prove that the
morphological changes observed in the triterpene-treated astro-
cytes were associated with alterations in the cytoskeleton, we
examined the organization of cytoskeletal proteins, F-actin and
vimentin (Fig. 3A). In resting cells, F-actin appeared in a well
organized crossing pattern of stress fibbers that traverses the whole
cell. When cells were exposed to 25 and 50 mM of erythrodiol or
uvaol, this organized system of actin cables looked completely
disrupted, being more relevant at the highest doses. This rapid
depolymerization and breakdown of actin determined that the
stress fibers were no longer evident, and the F-actin staining was
found diffuse throughout the cytoplasm and also in the long and
thin cellular projections. The staining and distribution pattern of
vimentin in triterpenes-treated cells also revealed an altered
assembly, following a similar model to that found for F-actin.
Control cells displayed vimentin staining as a complex mesh of
fibbers, most evident in a perinuclear distribution within the cell
body. After triterpene treatment, this network of fibers packed
together into a continuous dense bundle along the cellular
processes.
Then, to assess whether the cytoskeletal rearrangements were
associated to nuclear alterations, we tested for an increase in
nuclear/chromatin fragmentation. Cells were seeded in standard
tissue culture plates and after 18 h of exposure to triterpenes,
although some of the 1321N1 astrocytes kept anchorage onto the
coverslips (Fig. 3B upper panels), most of them were in suspension
(Fig. 3B lower panels), so we also collected them for fluorescence
microscopy analysis. DAPI staining revealed that in the presence
of uvaol, both attached and floating cells showed clear apoptotic
features, such as nuclear fragmentation, while after erythrodiol
treatment nuclear changes were only found in the detached cells.
Next, to achieve better adhesion settings, cells were seeded onto
poly-L-lysine-treated coverslips (Fig. 3C). In these conditions no
nuclear fragmentation was detected in erythrodiol treated-cells.
Conversely, the presence of uvaol in this adherent situation
induced a nuclear morphology characteristic of the apoptotic
process.
Effect of triterpenic alcohols on 1321N1 cell growth and
survival
The effect of erythrodiol and uvaol on survival of 1321N1
astrocytoma cells was determined by [3H]-thymidine incorpora-
tion, PI staining, and annexin-V binding [37,38].
The thymidine uptake assay confirmed that DNA synthesis was
significantly inhibited in cells treated with 1–50 mM triterpenes
(Fig. 4A). The resulting growth curves showed a dose-dependent
inhibitory effect. erythrodiol-treatment inhibited 1321N1 prolifer-
ation at lower IC50 than uvaol.
Next, the cell cycle distribution was examined under the same
conditions (Fig. 4B). A hallmark of apoptosis in the cells is the
generation of DNA fragments, which leads to a characteristic
hypodiploid pattern, readily distinguishable by flow cytometry
analysis after PI staining. Thus, cell cycle analysis revealed a
progressive accumulation of cells in the subdipliod phase (sub-G1)
of the cycle upon exposure to triterpene. Again, the effect with
uvaol was smaller than with erythrodiol at the same concentration.
Apoptotic rate in erythrodiol- and uvaol-treated cells increased in
a dose-dependent manner, from 1.1% to 55.3%, and from 2% to
35%, respectively. Moreover, another apoptotic feature is the
appearance of phosphatidylserine (PS) on the cell surface, which
can be determined by an annexin-V binding assay. As shown in
Fig. 4C, after 18 h of exposure to triterpenes, around 70–80% of
the cells treated with 25–50 mM of erythrodiol and 40–60% of the
cells treated with 50–100 mM of uvaol, displayed annexin-V
binding. Taken together, these results suggest that alcoholic
triterpenes trigger apoptotic cell death in 1321N1 astrocytes.
Erythrodiol and uvaol trigger JNK activation on 1321N1
cells
The stress activated c-Jun N-terminal kinase (JNK) pathway is
known to be involved in the regulation of apoptotic death in
most cellular types [13]. Therefore, we explored whether JNK
were activated in triterpene-treated cells, through an in vitro
kinase assay.
As shown in Fig. 5A, both erythrodiol and uvaol modulate JNK
activity. The maximum level of activation was observed after 4 h
of stimulation with either drug. Dose-dependent studies (Fig. 5B)
showed, once more, that cells were more sensitive to erythrodiol
than to uvaol. The highest JNK activity was obtained at 25 mM of
erythrodiol and at 50 mM of uvaol, which parallels with the
concentrations required for apoptosis of this cell line.
Next, we studied the effect of the pharmacological inhibition of
JNK on cell death events. 1321N1 cells were treated with different
doses of the specific JNK inhibitor SP600125 before exposure to
triterpenes, and then, analyzed under light microscopy (Fig. 5C) or
stained with annexin-V for apoptosis evaluation (Fig. 5D). As
shown in Fig. 5D, triterpene-induced cell death was markedly
reversed by pretreatment with SP600125 in a concentration
dependent manner. The cellular viability in control 1321N1
astrocytes was not affected by the inhibitor at the doses tested.
These findings were confirmed by morphological examination of
the cells under a contrast-phase microscope.
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Figure 2. Erythrodiol and uvaol induce detachment on 1321N1 astrocytoma cells. A, Morphological appearance of the cells exposed to
different doses of erythrodiol or uvaol for 6 h (upper panels) or to 25 mM erythrodiol or 50 mM uvaol for different times (lower panels). Cells were
visualized under a phase contrast microscope Nikon Eclipse TS100 (620). B, Cells were treated with different doses of erythrodiol or uvaol for 18 h.
The expression of CD44, ICAM and VCAM was determined by flow cytometry. Histograms represent one experiment out of three. Solid gray curves
represent unspecific binding; empty black curves, cells cultured in the absence of treatment (control); and empty gray curves, triterpene-treated cells.
doi:10.1371/journal.pone.0005975.g002
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Figure 3. Erythrodiol and uvaol induce morphological changes in the cytoskeleton. A, Cells were treated with different doses of
erythrodiol or uvaol for 6 h. Then, cells were stained with FITC-phalloidin (green, b, e, h, k and n) or anti-vimentin Ab (red, c, f, i, l and o) and visualized
under a fluorescent microscope (660). Cells were seeded on standard conditions (B) or in poly-L-lysine treated coverslips (C). After 18 h of exposure to
25 mM of triterpenes, floating cells (B lower panels) and attached cells (B upper panels and C) were fixed and stained with DAPI. Cells were visualized
using a Nikon Eclipse 80i fluorescent microscope (660). The cellular morphology was observed using Nomarski optics. The floating population from
the adherent condition was too low to be evaluated.
doi:10.1371/journal.pone.0005975.g003
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Erythrodiol and uvaol cause reactive oxygen species
accumulation
Next, we asked whether erythrodiol or uvaol treatment were
associated with changes in intracellular ROS levels. To examine
this possibility, cells were loaded with the permeable and redox-
sensitive dye, DCFH-DA and ROS production was assessed in the
absence or presence of 5–50 mM of either erythrodiol or uvaol. In
Fig. 6A upper pannel, the results demonstrate a dose-dependent
increase in DCF fluorescence at 30 min of triterpene exposure.
The mean fluorescence intensity (MFI) was 3.1 in non-treated
cells, while after erythrodiol treatment was 5.3 at 5 mM, 10.1 at
25 mM, 15.1 at 50 mM and 14.85 at 100 mM. Similar MFI were
obtained from uvaol-exposed 1321N1 cells. RNS production was
also examined using the DAF-FM dye, but no oxidation was
observed at any condition (data not shown).
It has been suggested that ROS overproduction leads to a
reduction in the mitochondrial membrane potential (DYm) as well
as mitochondrial dysfunction. Therefore, to detect these changes
of DYm, the specific fluorescent probe Rhodamine 123 (Rh 123)
was used (Fig. 6A lower panel). Rh 123 is a dye whose uptake and
retention into the mitochondrial matrix depends on the membrane
potential. Compared to untreated control cells, exposure of the
cells to 25 mM erythrodiol or 50 mM uvaol for 6 or 18 h caused a
disruption of DYm, as evidenced by a shift to the left in the
fluorescence curves. Figure 6A lower panel, shows that both
treatments caused a significant MFI decreased (p,0.001), for
erythrodiol it dropped to 334.8613,5 at 6 h and 184633 at 18 h,
and for uvaol was 278.7610.5 at 6 h and 96.5623 at 18 h, as
compared with 929631 in untreated control cells. These findings
were confirmed by examination of the cells under a fluorescence
microscope. Control cells were stained extensively with Rh123,
whereas the triterpene-treated cells were less stained or not stained
at all.
In addition, triterpene-induced reduction in DYm was com-
pletely abrogated by catalase pretreatment (Fig. 6B). The sum of
these results suggests that erythrodiol or uvaol induce DYm
dissipation in an antioxidant-sensitive pathway and it indicates
that triterpene-mediated generation of ROS causes the reduction
of DYm.
ROS induced by triterpenic alcohols mediate JNK
activation and apoptosis
To determine whether the pro-oxidant effects of triterpenes
participate in erythrodiol- or uvaol-induced JNK activation and
Figure 4. Effects of triterpenic diols on cell growth and apoptosis in 1321N1 cells. A, The cells were exposed to different doses of
erythrodiol or uvaol for 18 h in the presence of FCS and proliferation was determined by a [3H]-thymidine uptake assay. Data are expressed as the
percentage of radioactivity incorporated in FCS-stimulated cells in the absence of triterpenes (327.51063.889 dpm). B, C, Cells treated as above, but
without FCS, were fixed in 70% ethanol and stained with PI (B) or stained with annexin-V-PE (C) and analyzed by flow cytometry. The numerical values
are presented as the mean6S.D. of three independent experiments. Percentages in B indicate the number of cells in the sub–G0-G1 phase of the cell
cycle. *p,0.05, **p,0.01, ***p,0.001 vs control untreated cells.
doi:10.1371/journal.pone.0005975.g004
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apoptosis, astrocytoma cells were pretreated with different
concentrations of the ROS-scavenging enzyme, catalase. First,
we determined the ability of this antioxidant enzyme to reduce the
DCF fluorescence on triterpene-treated cells. As shown in Fig. 6B,
the accumulation of intracellular ROS induced by erythrodiol or
uvaol was completely abolished in the presence of 100 U/ml of
catalase. Then, to find out whether oxidative stress was responsible
for the activation of JNK, an in vitro kinase assay was performed
with cells that were treated with different concentrations of the
scavenger enzyme before exposure to erythrodiol or uvaol. The
Figure 5. Effect of triterpenic diols in JNK activation. Cells were stimulated with 25 mM erythrodiol or 50 mM uvaol at the indicated times (A), or
with different doses of erythrodiol or uvaol for 4 h (B), and assayed for an in vitro JNK-kinase assay as described in Materials and Methods. Exposure to
200 U/ml of TNF for 15 min was used as positive control. Results are representative of four separate experiments. Cells were exposed to different
doses of SP600125 in the presence of 25 mM erythrodiol or 50 mM uvaol for 18 h. Then, the cells were analyzed by phase-contrast microscopy using a
Nikon Eclipse TS100 microscope (640; C) or labeled with annexin V–PE and analyzed by flow cytometry (D). In the histograms, cells obtained after
triterpene treatment in the absence of the inhibitor (open black curves) are compared with cells treated in the presence of the inhibitor (open gray
curves). Gray solid curves, resting control cells. *p,0.05, **p,0.01, vs triterpenes treated cells in the absence of the inhibitor.
doi:10.1371/journal.pone.0005975.g005
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results showed that triterpenes-induced JNK activation was
abrogated by catalase in a dose-dependent manner and the
maximal effect was obtained at 500 U/ml. (Fig. 6C).
Finally, to further characterize the apoptotic response induced
by the alcoholic triterpenes, the effect of catalase on the triterpene-
induced cell death was determined morphologically under
contrast-phase microscopy and by FACS analysis after annexin-
V labelling (Fig. 6D). The results showed that the presence of the
scavenger enzyme reduced in a dose-dependent manner the cell
surface staining and attenuated the morphological changes elicited
Figure 6. ROS-dependent JNK activation contributes to triterpenes-stimulated apoptosis. A, Analysis of ROS production and DYm
evaluation. Cells were treated with different doses of erythrodiol or uvaol for 30 min: 5 mM (black empty curve), 25 mM (dark grey empty curve) or
50 mM (light gray empty curve), and then stained with DCFH-DA (upper histograms), or treated with 25 mM erythrodiol or 50 mM uvaol for 6 h (black
empty curve) or 18 h (gray empty curve) and staining with Rh123 (lower histograms). Intracellular ROS and DYm was monitored by flow cytometry or
under a fluorescence microscope (640). B, Cells were preincubated with catalase, treated with 25 mM erythrodiol or 50 mM uvaol for 30 additional min
and stained with DCFH-DA (upper histograms) or for 18 h and staining with Rd123 (lower histograms), and analyzed by flow cytometry. C, Cells were
preincubated with different doses of catalase, treated with 25 mM erythrodiol or 50 mM uvaol for 4 h and assayed for an in vitro JNK-kinase assay.
Exposure to 200 U/ml of TNF for 15 min was used as positive control. D, Cells were preincubated with catalase, treated with 25 mM erythrodiol or
50 mM uvaol for 18 h, stained with annexin-V-PE and analyzed under light microscope (640) or by flow cytometry. In the histograms, cells obtained
after triterpene treatment in the absence of the antioxidant (open black curves) are compared with cells treated in the presence of the antioxidant
(open gray curves). In all the histograms, the solid grey curve represent the resting/control cells. The results are representative of three independent
experiments.
doi:10.1371/journal.pone.0005975.g006
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by triterpenes in 1321N1 cells. Therefore, the percentage of
annexin V-PE-positive cells observed in erythrodiol- and uvaol-
treated astrocytes decreased dramaticaly in the presence of
500 U/ml catalase, 70% vs. 43%, (p,0.01), and 60% vs. 18%
(p,0.05), respectively, confirming the involvement of ROS in the
process under study.
Erythrodiol and uvaol upregulate some proteins of the
TNF/TNFR family in 1321N1 cells
Possible pathways for erythrodiol- and uvaol-regulation of the
cellular apoptosis threshold include the modulation of death
receptor/ligand systems. Therefore, TNFR1, Fas, and FasL
expression were measured by using flow cytometry analysis. As
shown in Fig. 7A, a high proportion of 1321N1 cells constitutively
expressed cell-surface TNFR1 and Fas, and the presence of 25 mM
erythrodiol or 50 mM uvaol for 18 h was sufficient to markedly
increase its cell surface expression. In addition, although these cells
constitutively lack expression of FasL, we found it up-regulated
upon triterpenes treatment. Similar results were also observed for
CD40, another member of the TNFR superfamily.
Next, we wondered whether these death systems might account
for a part of the mechanism of the triterpenic diols-induced
apoptosis. As shown in Fig. 7B, we found that the presence of
neutralizing anti-Fas or anti-FasL mAbs failed to significantly
protect astrocytoma cells from the triterpenes-apoptotic effects,
measured using annexin V-PE and flow cytometric analysis.
Similarly, we found that CD40 ligation neither promoted annexin-
V binding in resting 1321N1 astrocytes (data not shown), nor co-
incubation with erythrodiol or uvaol affected the apoptotic
response elicited by triterpenes in these cells. Therefore, we
determined that these systems didn’t play a role in transducing the
apoptotic signals triggered by erythrodiol or uvaol.
Apoptosis induced by treatment with erythrodiol or
uvaol is a general event in cancer cell lines
To know whether the apoptotic response induced by treatment
with either erythrodiol or uvaol was cell-specific or a general
phenomenon, we performed the annexin-V binding assay in other
human cancer cells independently of their p53 status, including,
MCF7, HepG2, HeLa and three gliomas such as U373, U118 and
U87. After 18 h exposure to 25–50 mM of erythrodiol or uvaol, all
cell types under study bound annexin-V to a significantly higher
degree than control-untreated cells, indicating that all of them
underwent programmed cell death. The extent of the effects
observed varied from cell to cell, and in all cases cells were
substantially more sensitive to erythrodiol than to uvaol (Fig. 8).
Discussion
Promising new molecules, especially those from natural origins,
are being examined as therapeutic agents, since natural com-
pounds are considered safe, as they are derived from commonly
consumed foodstuff. Many reports have shown the anti-prolifer-
ative properties of triterpenes against multiple tumoral cells, being
the acidic ones the most frequently studied [33–36]. In fact, to
improve their activities, synthetic analogs of oleanolic acid have
been developed and actually are under clinical evaluation as anti-
tumoral therapeutic agents for hematologic malignancies. Sur-
prisingly, in spite of the lack of effective treatments for brain
tumors, little attention has been paid to these lipophilic agents
capable of crossing the BBB [16–18]. In this study, we evaluated
on astrocytoma cells the antitumoral activity of two alcoholic
triterpenes, erythrodiol and its isomer uvaol, as well as their
actions on some key players of the apoptotic response.
First of all, we show that both triterpenic diols are potent
inhibitors of 1321N1 cells proliferation in a time- and dose-
dependent manner. We also observe that this growth- inhibiting
activity is associated with the induction of apoptosis. Treatment of
1321N1 cells with either erythrodiol or uvaol results in the
appearance of apoptosis-specific hallmarks, such as redistribution
of cells into the subdiploid phase of the cell cycle, translocation of
phosphatidylserine to the outer leaflet of the cellular membrane,
fragmentation of nuclei, and, production of ROS, which are
accompanied by the fall in DYm. In addition, astrocytes undergo
morphological changes normally associated with cell injury,
indicating widespread alterations of the cytoskeletal framework.
Cytoskeletal elements known to be reorganized during apoptosis
include: actin microfilaments, microtubules, and intermediate
filaments [39]. Thus, both by phase-contrast and fluorescence
microscopy, we have shown that triterpenes cause retraction,
rounding and shrinking of cultured cells, and elicit actin and
vimentin filaments rearrangement: microfilaments and intermedi-
ary filaments dissolve, and an amorphous and condensed pattern is
observed. Furthermore, cells show a significant reduction in the
ability to both adhere and spread, and an altered expression levels
of the standard form of CD44 is also observed, especially in
erythrodiol treated cells. It is well known that the communication
cell-cell and cell-extracellular matrix is facilitated by molecules like
CD44, and a direct relationship between CD44 expression, actin
filaments and the level of cell malignancy and resistance to cell
death-inducing stimuli has been established [40,41]. Therefore,
the decrease in CD44 expression induced by triterpenic diols
treatment may be one of the potential mechanisms coupled to the
regulation of 1321N1 cell anchorage and death.
On the other hand, upon erythrodiol or uvaol treatment we also
observe an upregulation of some members of the immunoglobulin
super family, such as VCAM and ICAM that, at first sight, is not
consistent with the antiadhesive and antiinflamatory effects of
triterpenes. However, these receptors require clustering and
association with actin-based structures for functional activity
[42–44]; and it has been previously shown that disruption of the
actin cytoskeleton not only influences cell surface distribution, but
also increased surface expression of the ICAM-1 protein [45]. This
means, that cytoskeletal disruption induced by triterpenes may
alter the surface distribution of adhesion molecules, impeding their
clustering, which eventually may result in reduced adhesion of
1321N1 cells regardless of their expression levels.
Interestingly, all these features also mimic those observed during
a process named anoikis, a programmed cell death induced by the
loss of anchorage. In fact, changes in cell shape and cytoskeleton
might be considered a potential cause of anoikis. Cells adhere to
natural extracellular matrices, via integrin-dependent interactions,
as well as non-integrin-recognizable matrices such as poly-L-lysine.
According to many studies, these interactions play an important
role in survival and suppression of anoikis [46,47]. In our study,
the attachment of 1321N1 cells to poly-L-lysine matrix suppresses
the apoptotic nuclear morphology induced after erythrodiol
exposure. However, uvaol treatment either under adherent or
standard conditions yields the same results, cells with condensed
and fragmented nuclei. For this reason, we suggest the possibility
that erythrodiol, but not uvaol, might induce cell death by anoikis
in 1321N1 astrocytes. This is an interesting question for future
studies, especially if we consider anoikis as a barrier to metastasis.
Extensive and recent studies about the functional properties of
this pro-apoptotic family of drugs have suggested modulation of
different key molecules as being responsible for its actions,
depending on the triterpene and the cellular type. Thus, it has
been reported for the synthetic oleanane CDDO-Me, modulation
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Figure 7. Effect of triterpenic diols on the expression and activity of death receptor/ligand systems. A, The expression of TNFR1, CD40, Fas
and FasL was determined by flow cytometry, in 1321N1 cell exposed to 25 mM erythrodiol or 50 mM uvaol for 18 h. Histograms represent one
experiment out of three. Solid gray curves represent unspecific binding; empty black curves, cells cultured in the absence of treatment (control); and
empty gray curves, triterpene-treated cells. B, Cells were treated with 25 mM erythrodiol or 50 mM uvaol, in absence (black empty curve) or presence (grey
empty curve) of anti-CD40, anti-Fas or anti FasL antibodies for 18 h. Afterward, the cells were labeled with annexin-V PE and analyzed by flow cytometry.
doi:10.1371/journal.pone.0005975.g007
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Figure 8. Effect of triterpenic diols on different tumor cell types. The indicated cell types were treated without or with 25 mM (black empty
curve) or 50 mM (grey empty curve) of erythrodiol or uvaol for 24 h and stained with annexin-V PE. Solid gray curves represent labeling of resting/
control cells.
doi:10.1371/journal.pone.0005975.g008
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of Akt, NF-kB and Notch1 on gliomas [48] and JNK-mediated
DR up-regulation on lung cancer cells [49]. On the other hand,
betulinic acid has been demonstrated to promote degradation of
the transcription factors Sp1, Sp3, and Sp4 on prostate cancer cells
[50], while on melanoma cells it elicits a transient activation of the
EGFR/ERK/AKT pathway [51] or promotes sequential effects
on ROS accumulation and caspases activation on glioma cells
[52]. In addition, endometrial cancer cells exposed to ursolic acid
showed an inhibition of the PI3K/Akt and MAPK cascades [53],
whereas JNK- and p38 kinase-mediated mitochondrial pathways
participate in the apoptosis induced by echinocystic acid in
HepG2 cells [54]. In this perspective, the present study shows that
triterpene diols-induced JNK activation is mediated by ROS
imbalance. It is likely that the main ROS formed is hydrogen
peroxide, because addition of exogenous catalase suppresses
1321N1-DCF fluorescence, while superoxide dismutase fails to
do so (data not shown). Moreover, pretreatment with catalase
abrogates perturbance of DYm, JNK activation and rescues
astrocytoma cells from triterpene-induced damage, indicating that
ROS is the up-regulator of JNK activation during triterpene
dialcohols-induced apoptosis. Interestingly, further investigations
of mitochondria-associated apoptotic events also indicate involve-
ment of caspase-3. Thus, the ratio of cells with activated caspase-3,
rise from 6.564% in untreated cells to 31.364%, (p,0.05), and
2364.8%, (p,0.05), upon 6 h of 25 mM ERY or 50 mM UV
treatment, respectively (data not sown). However, the apoptotic
response induced by other triterpenes such as betulinic acid,
although also involve ROS generation upstream of the activated
JNK, programmed cell death occurs independently of key caspases
on melanoma cells [55].
In anticancer therapy, another key signaling mechanism known
to play a role in the execution of apoptosis is the Fas/FasL system
[56]. However, the role of this diad in brain tumors is
controversial, since it has been observed that some tumors of the
CNS expressing Fas/FasL are resistant to apoptosis induction
[57]. In this regard, our study indicates that both markers are
increased in erythrodiol- or uvaol-treated 1321N1 cells, as well as
other proteins belonging to the TNFR superfamily such as
TNFR1 or CD40. These findings are consistent with earlier data
reported for others triterpene [58]. However, though 1321N1 cells
are sensitive to Fas-mediated apoptosis (data not shown), this
pathway has been discarded based on the inability of exogenously
added anti-Fas/FasL blocking antibodies to attenuate triterpenic
diols-induced apoptosis. Nevertheless, the possibility that a Fas/
FasL suicidal interaction may take place in an intracellular
compartment and, thus, is not accessible to exogenously added
reagents can not be rejected [59]. In addition, our studies reveal
that the up-regulated CD40 and TNFR1 are not required for
triterpene-mediated apoptosis. Since, 1321N1 cells are neither
sensitive to death after CD40 ligation, nor combining receptor
ligation with exposure to triterpenic diols affect the response
induced by the triterpene alone. Likewise, TNFR1 blockage does
not affect triterpene cell death (data not shown). However,
although these proteins are not mediators of the triterpenes-
apoptotic pathway, they may be up-regulated to collaborate with
the apoptotic program.
Furthermore, we find that erythrodiol and uvaol are able to
induce apoptosis (in a dose-dependent manner) in other solid
tumors cell lines irrespective of their p53 status, suggesting that
their actions are not cell specific, but a generalized event.
In conclusion, our novel findings indicate that natural alcoholic
triterpenes are powerful inhibitors of cell growth and efficient
apoptotic killing agents and suggest that these processes are
mediated by the activation of a ROS/JNK pathway.
Materials and Methods
Reagents
FITC-conjugated phalloidin, DAPI, PI, catalase, Rhodamine
123 and chemicals were from Sigma (St. Louis, MO). DCFH-DA
and DAF-FM were from Molecular Probes (Eugene, OR). [3H]-
Thymidine was from Amersham Biosciences (Little Chalfont,
UK). SP600125 was from Cabiochem (San Diego, CA).
Glutathione S-transferase (GST) fusion protein with amino acids
1–223 of the NH2-terminal portion of c-Jun protein was a gift from
Dr. C. Caelles (IRB, Barcelona). For blocking experiments, the
neutralizing mAbs NOK-2 (anti-FasL) (Pharmingen, San Diego,
CA, USA) and SM1/23 (anti-Fas) (Alexis, Gru¨nberg, Germany)
were used at a concentration of 10 mg/ml.
Erythrodiol and Uvaol
Erythrodiol and uvaol were from Extrasynthesis (Genay,
France). Triterpenes solutions at 25 mM in EtOH were stored
at 220uC and diluted to the final concentration in fresh media
before each experiment. The final EtOH concentration used
did not exceed 0.5%, so as not to affect the cellular responses.
Structures are shown in Figure 1. For analytical assessment of
purity and identity, erythrodiol and uvaol were converted into
their trimethylsilyl (TMS) derivatives with TMSIM (N-
Trimethylsilylimidazole), the preferred reagent for the silylation
of the all hydroxyl groups, followed of GC/MS analysis
[60,61].
Conditions for GC-ion-trap-MS analysis. The GC-ion-
trap-MS experiments were performed using a Finnigan Trace-GC
2000 gas chromatograph coupled to a Polaris-Q Ion trap mass
spectrometer (ThermoFinnigan, Austin, TX, USA). The column
used was a Zebron ZB-5 ms (Phenomenex, Torrance, CA, USA)
fused silica capillary column (30 m long60.25 mm i.d60.25 m
film thickness). The GC conditions included helium as carrier gas
at 1 mL min21 in constant flow mode. The initial temperature of
105uC was kept for 1 min, then raised to 290uC at a rate of 10uC/
min and hold for 20 min. Injector temperature was 290uC and
samples were inyected in split mode .
The MS operating conditions were as follows. ion source
and transfer line temperatures were 200 and 290uC, respectively.
The electron energy was 70 eV, resolution was unit and the
emission current was 250 mA.
The Xcalibur version 1.4 software was used for data acquisition
and processing of the results. Mass spectral identification was done
by matching with those of the Wiley MS database and comparing
the spectra to the literature.
Mass spectra of TMS derivatives of erythrodiol and uvaol
showed a common fragmentation pattern: is spite the molecular
ion is minimal or not present, it can be easily deduced by presence
of loss of methyl group [M–CH3 ] at m/z 571, tipycal of silylated
compounds, and a intense neutral loss of the TMSiOH group at
m/z 496 that represent the base peak of the spectra of either
compounds.
Cell lines and cultures
The human astrocytoma cell lines 1321N1, U87 MG (U87),
U181 MG (U181) and U373 MG (U373) were a gift from Dr J.
Brown (UCSD, USA), Dr M. Guzman, (UCM, Spain), and Dr M.
Izquierdo (UAM, Spain), respectively. The human carcinoma cell
lines: breast MCF-7, cervix HeLa and hepatoma HepG2, were a
gift from Dr. J.L. Bos (UMC, The Netherlands).
Cell lines were cultured under standard conditions in DMEM
supplemented with 10% FCS as described [37].
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Cell morphological studies
Astrocytes were seeded on 16 mm glass coverslips. After
triterpenoid treatment, cells were fixed with 3.7% formaldehyde,
permeabilized in PBS containing 0.1% Triton X-100 and
examined for morphological changes. In addition, the cells were
incubated at 37uC in the dark for 30 min, with FITC-phalloidin
(1:200) and anti-vimentin antibody (1:200) followed by incubation
with Alexa 546-conjugated goat anti-mouse IgG antibody to
visualize F-actin and vimentin. Cellular nuclei were detected by
incubation with 1 mg/ml DAPI in the dark for 5 min. Thereafter,
cells were washed with PBS and images were captured with either
a Nikon Eclipse TS100 or a Nikon Eclipse 80i inverted
fluorescence microscope using 206, 406 or 606 objective lenses.
Cell cycle analysis
Cells were seeded at the density of 56105 in 25-cm2 flasks. After
24 h, they were treated with or without different doses of triterpenes
for 18 h, washed twice with cold PBS, and fixed with 70% ethanol.
Then, RNA was removed by digestion with RNase A at room
temperature, and cells were analyzed on an EPICS XL cyto-
fluorometer (Beckman Coulter, Spain) after propidium iodide
labelling. Data analysis was performed using WinMDI 2.7 software.
Cell proliferation
Cell proliferation was evaluated with a [3H]-thymidine uptake
assay [38]. Quiescent cells were treated with 5% FCS in the
presence of 0, 1, 5, 25 or 50 mM of erythrodiol or uvaol for 24 h.
Cells were then pulsed with 0.5 mCi [3H]-thymidine/well for 4 h
before harvesting and the radioactivity incorporated was measured
by liquid scintillation counting. Numerical data are expressed as
mean6S.D. of three experiments, each performed in triplicate.
Assays for ROS/RNS Production, and Mitochondrial
Transmembrane Potential
The intracellular generation of ROS/RNS was measured using the
cell-permeable probes 29,79-dichlorofluorescein diacetate (DCFH-
DA) and 4-Amino-5-methylamino-29,79-difluorofluorescein diacetate
(DAF-FM diacetate). Briefly, cells in 25-cm2 flasks were treated for
30 min with 1 mM DCFH-DA or DAF-FM and stimulated 30 min
with 25 mMof erythrodiol,50 mM of uvaol, orEtOH.Then, cells were
harvested, washed in PBS, and analyzed by flow cytometry. In some
experiments, cells were treated for 30 min with the indicated dose of
catalase before incubation with the triterpenes.
To measure the mitochondrial transmembrane potential, cells
were treated with the cationic dye Rh123. Cells in 25-cm2 flasks
were treated with 25 mM of erythrodiol, 50 mM of uvaol or EtOH
for 6 or 18 h. Then, Rh123 was directly added to the culture
medium to a final concentration of 150 nM. Cells were harvested
and analyzed for fluorescence intensity by flow cytometry or
fluorescence microscopy.
Flow Cytometric Analysis of Apoptotic Cells
After exposure to the indicated doses of erythrodiol or uvaol for
18 h the apoptotic cell death was determined using an Annexin V-
PE Apoptosis Detection Assay, as described [33]. Briefly, cells
were incubated in binding buffer with R-phycoerythrin- annexin-
V antibody for 5 min, followed by flow cytometric analysis. In
some experiments, cells were pretreated for 30 min with different
doses of either catalase or SP600125.
Flow Cytometry of Membrane Proteins
1321N1 cells were assayed for CD44, VCAM, ICAM, TNFR,
CD40, Fas, and FasL expression. For this purpose, 56106 cells/
dish were treated with the agonists for 18 h. Then, the cells were
collected, suspended in PBS supplemented with 1% BSA and
incubated with 10 mg/ml of : anti-human CD44 (A3D8), CD40
(5C3), ICAM (HA58), TNFR1 (MAB), VCAM mAbs; 1 mg/mL of
FasL NOK-1 mAb, or 500 ng/mL of Fas DX2 mAb (BD
Biosciences Pharmingen) for 1 h at 4uC. After washing, goat anti-
mouse IgG-FITC conjugate (Sigma) 1:100 was added and
incubated for 30 minutes at 4uC. Subsequently, cells were washed
and analyzed by flow cytometry. Positive cells were estimated
using an isotype-matched control negative Ab at an equivalent
concentration. Data were analyzed using WinMDI 2.7 software.
Assay of JNK Activity
JNK assays were performed using GST-c-Jun as substrate, as
described [34]. The substrate GST-c-Jun was expressed in bacteria
E. coli XL-1 Blue using a pGEX-2T plasmid and purified with
glutathione-agarose beads. The cytosolic extracts for the kinase
assay were obtained from the lysis of 56106 cells. After
centrifugation, the supernatant was mixed with 10 mg of GST-
c-Jun protein and glutathione agarose beads. The mixture was
incubated at 4uC for 3–5 h. Phosphorylated GST-c-Jun was
resolved by 10% SDS/PAGE and immunodetected by Western
blot using rabbit phosphospecific c-Jun (Ser63) antibody (Santa
Cruz Biotechnology Inc, Santa Cruz, Calif).
Statistical Analysis
Differences among the various treatment groups were deter-
mined by analysis of variance (ANOVA) followed by the
Bonferroni’s multiple comparison test with the GraphPad Prism
Version 4 software (San Diego, CA). P-values lower that 0.05 were
considered significant.
Supporting Information
Figure S1 GS-MS chromatograms. GS-MS chromatograms.
Gas Chromatography chromatograms in full scan mode of TMS
derivatives of uvaol (A) and erythrodiol (C). Single peaks with
retention times at 30.7 and 29.7 minutes, respectively, indicated
that the preparation was .99% pure Gas chromatography ion-
trap mass spectra of TMS derivatives of uvaol (B) and erythrodiol
(D)
Found at: doi:10.1371/journal.pone.0005975.s001 (0.93 MB TIF)
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